Senate committee approves pharmacy rule rewrite after compounding debate; removes two compounding subsections

The Senate Health and Welfare Committee on Tuesday approved a pending rule chapter from the Idaho State Board of Pharmacy that rewrites more than 35 sections of the board's rules, but the committee struck two subsections of a compounding labeling provision after stakeholder concerns.

The board presented docket 24-3601-2402 and asked the committee to adopt the pending rules as final. Nikki Chopsky, bureau chief of health professions for the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy, told the committee the rewrite moves duplicative material into statute and reorganizes the chapter by authority, scope, definitions, licensure, practice standards, discipline, fees, compounding and prescription drug monitoring.

"The board took a comprehensive review of its rules and made more than 35 changes to this chapter," Chopsky said. She told senators the rewrite removes duplicated statutory language, combines scattered…